Skip to main content
Top
Published in: Annals of General Psychiatry 1/2015

Open Access 01-12-2015 | Primary research

Prevalence and risk factors for depression in women with multiple sclerosis: a study from Iran

Authors: Khadijeh Mohammadi, Parvin Rahnama, Ali Montazeri

Published in: Annals of General Psychiatry | Issue 1/2015

Login to get access

Abstract

Background

Multiple sclerosis is increasingly becoming a major health problem among women worldwide. The aim of the present study was to estimate prevalence of depression in women with multiple sclerosis and also to identify risk factors contributing to its development.

Methods

This was a cross-sectional study of depression in a sample of 226 women with multiple sclerosis. The sample was recruited from an outpatient clinic in Tehran, Iran. Depression was assessed using the Beck Depression Inventory-II (BDI-II). Univariate and multiple logistic regression analyses were performed to examine the association between depression and independent variables.

Results

Overall, 91 women (40.2 %) had moderate to severe depression. The mean age of participants was 35.7 years (SD = 8.07). The results obtained from multiple logistic regression analysis showed that the disease course (OR for relapsing–remitting MS = 2.36, % 95 CI = 1.14–5.53, P = 0.46), the expanded disability status scale (OR for score of 5–8 = 4.88, % 95 CI = 2.51–11.06, P < 0.001) and employment status (OR for housewife = 4.75, % 95 CI = 1.55–14.58, P = 0.006) were significant contributing factors to depression in patients with multiple sclerosis.

Conclusions

The findings suggest that depression in patients with multiple sclerosis is multi-factorial and very much dependent to physical and social conditions of patients. The recognition of such conditions might help clinicians to manage patients more effectively.
Literature
1.
go back to reference Lily O, McFadden E, Hensor E, Johnson M, Ford H. Disease-specific quality of life in multiple sclerosis: the effect of disease modifying treatment. Mult Scler. 2006;12:808–13.CrossRefPubMed Lily O, McFadden E, Hensor E, Johnson M, Ford H. Disease-specific quality of life in multiple sclerosis: the effect of disease modifying treatment. Mult Scler. 2006;12:808–13.CrossRefPubMed
2.
go back to reference Sahraian MA, Khorramnia S, Ebrahim MM, Moinfar Z, Lotfi J, Pakdaman H. Multiple sclerosis in Iran: a demographic study of 8000 patients and changes over time. Eur Neurol. 2010;64:331–6.CrossRefPubMed Sahraian MA, Khorramnia S, Ebrahim MM, Moinfar Z, Lotfi J, Pakdaman H. Multiple sclerosis in Iran: a demographic study of 8000 patients and changes over time. Eur Neurol. 2010;64:331–6.CrossRefPubMed
3.
go back to reference Etemadifar M, Sajjadi S, Nasr Z, Firoozeei TS, Abtahi SH, Akbari M, Fereidan-Esfahani M. Epidemiology of multiple sclerosis in Iran: a systematic review. Eur Neurol. 2013;70:356–63.CrossRefPubMed Etemadifar M, Sajjadi S, Nasr Z, Firoozeei TS, Abtahi SH, Akbari M, Fereidan-Esfahani M. Epidemiology of multiple sclerosis in Iran: a systematic review. Eur Neurol. 2013;70:356–63.CrossRefPubMed
4.
go back to reference Hirst C, Ingram G, Pickersgill T, Swingler R, Compston DA, Robertson NP. Increasing prevalence and incidence of multiple sclerosis in South East Wales. J Neurol Neurosurg Psychiatry. 2009;80:386–91.CrossRefPubMed Hirst C, Ingram G, Pickersgill T, Swingler R, Compston DA, Robertson NP. Increasing prevalence and incidence of multiple sclerosis in South East Wales. J Neurol Neurosurg Psychiatry. 2009;80:386–91.CrossRefPubMed
5.
go back to reference Munger KL, Zhang SM, O’Reilly E, Hernán MA, Olek MJ, Willett WC, Ascherio A. Vitamin D intake and incidence of multiple sclerosis. Neurology. 2004;62:60–5.CrossRefPubMed Munger KL, Zhang SM, O’Reilly E, Hernán MA, Olek MJ, Willett WC, Ascherio A. Vitamin D intake and incidence of multiple sclerosis. Neurology. 2004;62:60–5.CrossRefPubMed
6.
go back to reference Etemadifar M, Maghzi AH. Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran. Mult Scler. 2011;17:1022–7.CrossRefPubMed Etemadifar M, Maghzi AH. Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran. Mult Scler. 2011;17:1022–7.CrossRefPubMed
7.
go back to reference Azizi F, Rais-Zadeh F, Mir SGA. Vitamin D deficiency in a group of Tehran population. Res Med. 2000;4:291–303. Azizi F, Rais-Zadeh F, Mir SGA. Vitamin D deficiency in a group of Tehran population. Res Med. 2000;4:291–303.
8.
go back to reference Hovsepian S, Amini M, Aminorroaya A, Amini P, Iraj B. Prevalence of vitamin D deficiency among adult population of Isfahan City, Iran. J Health Popul Nutr. 2011;29:149–55.PubMedCentralCrossRefPubMed Hovsepian S, Amini M, Aminorroaya A, Amini P, Iraj B. Prevalence of vitamin D deficiency among adult population of Isfahan City, Iran. J Health Popul Nutr. 2011;29:149–55.PubMedCentralCrossRefPubMed
9.
go back to reference Schubert DS, Foliar RH. Increased depression in multiple sclerosis patients: a meta- analysis. Psychosomatics. 1993;34:124–30.CrossRefPubMed Schubert DS, Foliar RH. Increased depression in multiple sclerosis patients: a meta- analysis. Psychosomatics. 1993;34:124–30.CrossRefPubMed
10.
go back to reference Silva AMD, Vilhena E, Lopes A, Santos E, Gonçalves MA, Pinto C, Moreira I, Mendonça D, Cavaco S. Depression and anxiety in a Portuguese MS population: associations with physical disability and severity of disease. J Neurol Sci. 2011;306:66–70.CrossRefPubMed Silva AMD, Vilhena E, Lopes A, Santos E, Gonçalves MA, Pinto C, Moreira I, Mendonça D, Cavaco S. Depression and anxiety in a Portuguese MS population: associations with physical disability and severity of disease. J Neurol Sci. 2011;306:66–70.CrossRefPubMed
12.
go back to reference Alarcia R, Ara JR, Martín J, Bertol V, Bestué M. Importance and factors related to chronic fatigue in multiple sclerosis. Neurologia. 2005;20:77–84.PubMed Alarcia R, Ara JR, Martín J, Bertol V, Bestué M. Importance and factors related to chronic fatigue in multiple sclerosis. Neurologia. 2005;20:77–84.PubMed
13.
go back to reference Ayatollahi P, Nafissi S, Eshraghian MR, Kaviani H, Tarazi A. Impact of depression and disability on quality of life in Iranian patients with multiple sclerosis. Mult Scler. 2007;13:275–7.CrossRefPubMed Ayatollahi P, Nafissi S, Eshraghian MR, Kaviani H, Tarazi A. Impact of depression and disability on quality of life in Iranian patients with multiple sclerosis. Mult Scler. 2007;13:275–7.CrossRefPubMed
14.
go back to reference Ghajarzadeh M, Sahraian MA, Fateh R, Daneshmand A. Fatigue, depression and sleep disturbances in Iranian patients with multiple sclerosis. Acta Med Iran. 2012;50:244–9.PubMed Ghajarzadeh M, Sahraian MA, Fateh R, Daneshmand A. Fatigue, depression and sleep disturbances in Iranian patients with multiple sclerosis. Acta Med Iran. 2012;50:244–9.PubMed
15.
go back to reference Mohammadi K, Rahnama P, Moayed SM, Sahraian MA, Montazeri A. Determinants of sexual dysfunction in women with multiple sclerosis. BMC Neurology. 2013;13:83.PubMedCentralCrossRefPubMed Mohammadi K, Rahnama P, Moayed SM, Sahraian MA, Montazeri A. Determinants of sexual dysfunction in women with multiple sclerosis. BMC Neurology. 2013;13:83.PubMedCentralCrossRefPubMed
16.
go back to reference Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O’Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “Mc Donald Criteria”. Ann Neurol. 2005;58:840–6.CrossRefPubMed Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O’Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “Mc Donald Criteria”. Ann Neurol. 2005;58:840–6.CrossRefPubMed
17.
go back to reference Kurtzke JF. Rating neurologic instrument in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–52.CrossRefPubMed Kurtzke JF. Rating neurologic instrument in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–52.CrossRefPubMed
18.
go back to reference Beck AT, Steer RA, Brown GK. Manual for the beck depression inventory-II. San Antonio: Psychological Corporation; 1996. Beck AT, Steer RA, Brown GK. Manual for the beck depression inventory-II. San Antonio: Psychological Corporation; 1996.
19.
go back to reference American Psychiatric Association. Diagnostic and statistical manual of mental disorders 4th ed. Washington, DC; 1994. American Psychiatric Association. Diagnostic and statistical manual of mental disorders 4th ed. Washington, DC; 1994.
20.
go back to reference Beck AT, Steer RA, Garbin MGJ. Psychometric properties of the beck depression inventory twenty-five years of evaluation. Clin Psych Rev. 1988;8:77–100.CrossRef Beck AT, Steer RA, Garbin MGJ. Psychometric properties of the beck depression inventory twenty-five years of evaluation. Clin Psych Rev. 1988;8:77–100.CrossRef
21.
go back to reference Mohammadkhani P, Dabson KS. Psychometric characteristics of beck depression inventory-II in patients with major depressive disorder. J Rehabil. 2007;8:80–6. Mohammadkhani P, Dabson KS. Psychometric characteristics of beck depression inventory-II in patients with major depressive disorder. J Rehabil. 2007;8:80–6.
22.
go back to reference Feinstein A, O’Connor P, Akbar N, Moradzadeh L, Scott CJ, Lobaugh NJ. Diffusion tensor imaging abnormalities in depressed multiple sclerosis patients. Mult Scler. 2010;16:189–96.CrossRefPubMed Feinstein A, O’Connor P, Akbar N, Moradzadeh L, Scott CJ, Lobaugh NJ. Diffusion tensor imaging abnormalities in depressed multiple sclerosis patients. Mult Scler. 2010;16:189–96.CrossRefPubMed
23.
go back to reference Arnett PA, Barwick FH, Beeney JE. Depression in multiple sclerosis: review and theoretical proposal. J Int Neuropsychol Soc. 2008;14:691–724.PubMed Arnett PA, Barwick FH, Beeney JE. Depression in multiple sclerosis: review and theoretical proposal. J Int Neuropsychol Soc. 2008;14:691–724.PubMed
24.
go back to reference Goeb JL, Even C, Nicolas G, Gohier B, Dubas F, Garré JB. Psychiatric side effects of interferon-beta in multiple sclerosis. Eur Psychiatry. 2006;21:186–93.CrossRefPubMed Goeb JL, Even C, Nicolas G, Gohier B, Dubas F, Garré JB. Psychiatric side effects of interferon-beta in multiple sclerosis. Eur Psychiatry. 2006;21:186–93.CrossRefPubMed
25.
go back to reference Mohr DC, Hart SL, Fonareva I, Tasch ES. Treatment of depression for patients with multiple sclerosis in neurology clinics. Mult Scler. 2006;12:204–8.CrossRefPubMed Mohr DC, Hart SL, Fonareva I, Tasch ES. Treatment of depression for patients with multiple sclerosis in neurology clinics. Mult Scler. 2006;12:204–8.CrossRefPubMed
26.
go back to reference Arnett PA, Barwick FH, Beeney JE. Depression in multiple sclerosis: review and theoretical proposal. J Int Neuropsychol Soc. 2008;14:691–724.PubMed Arnett PA, Barwick FH, Beeney JE. Depression in multiple sclerosis: review and theoretical proposal. J Int Neuropsychol Soc. 2008;14:691–724.PubMed
27.
go back to reference Provinciali L, Ceravolo MG, Bartolini M, Logullo F, Danni M. A multidimensional assessment of multiple sclerosis: relationships between disability domains. Acta Neurol Scand. 1999;100:156–62.CrossRefPubMed Provinciali L, Ceravolo MG, Bartolini M, Logullo F, Danni M. A multidimensional assessment of multiple sclerosis: relationships between disability domains. Acta Neurol Scand. 1999;100:156–62.CrossRefPubMed
28.
go back to reference Fassbender K, Schmidt R, Mofsner R, Kischka U, Kuhnen J, Schwartz A, Hennerici M. Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis. Arch Neurol. 1998;55:66–72.CrossRefPubMed Fassbender K, Schmidt R, Mofsner R, Kischka U, Kuhnen J, Schwartz A, Hennerici M. Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis. Arch Neurol. 1998;55:66–72.CrossRefPubMed
29.
go back to reference Chwastiak L, Ehde D, Gibbons L, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: epidemiological study of a large community sample. Am J Psychiatry. 2002;159:1862–8.CrossRefPubMed Chwastiak L, Ehde D, Gibbons L, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: epidemiological study of a large community sample. Am J Psychiatry. 2002;159:1862–8.CrossRefPubMed
30.
go back to reference Voss WD, Arnett PA, Higginson CI, Randolph JJ, Campos MD, Dyck DG. Contributing factors to depressed mood in multiple sclerosis. Arch Clin Neuropsychol. 2002;17:103–15.CrossRefPubMed Voss WD, Arnett PA, Higginson CI, Randolph JJ, Campos MD, Dyck DG. Contributing factors to depressed mood in multiple sclerosis. Arch Clin Neuropsychol. 2002;17:103–15.CrossRefPubMed
31.
go back to reference Confavreux C, Vukusic S. Age at disability milestones in multiple sclerosis. Brain. 2006;129:595–605.CrossRefPubMed Confavreux C, Vukusic S. Age at disability milestones in multiple sclerosis. Brain. 2006;129:595–605.CrossRefPubMed
32.
go back to reference Honarmand K, Akbar N, Kou N, Feinstein A. Predicting employment status in multiple sclerosis patients:the utility of the MS functional composite. J Neurol. 2011;258:244–9.CrossRefPubMed Honarmand K, Akbar N, Kou N, Feinstein A. Predicting employment status in multiple sclerosis patients:the utility of the MS functional composite. J Neurol. 2011;258:244–9.CrossRefPubMed
34.
go back to reference Zabad RK, Patten SB, Metz LM. The association of depression with disease course in multiple sclerosis. Neurology. 2005;64:359–60.CrossRefPubMed Zabad RK, Patten SB, Metz LM. The association of depression with disease course in multiple sclerosis. Neurology. 2005;64:359–60.CrossRefPubMed
35.
go back to reference Feinstein A, Kartsounis LD, Miller DH, Youl BD, Ron MA. Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive psychiatric and MRI follow up study. J Neurol Neurosurg Psychiatry. 1992;55:869–76.PubMedCentralCrossRefPubMed Feinstein A, Kartsounis LD, Miller DH, Youl BD, Ron MA. Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive psychiatric and MRI follow up study. J Neurol Neurosurg Psychiatry. 1992;55:869–76.PubMedCentralCrossRefPubMed
36.
go back to reference Moore P, Hirst C, Harding KE, Clarkson H, Pickersgill TP, Robertson NP. Multiple sclerosis relapses and depression. J Psychosom Res. 2012;73:272–6.CrossRefPubMed Moore P, Hirst C, Harding KE, Clarkson H, Pickersgill TP, Robertson NP. Multiple sclerosis relapses and depression. J Psychosom Res. 2012;73:272–6.CrossRefPubMed
37.
go back to reference Feinstein A, Magalhaes S, Richard JF, Audet B, Moore C. The link between multiple sclerosis and depression. Nat Rev Neurol. 2014;10:507–17.CrossRefPubMed Feinstein A, Magalhaes S, Richard JF, Audet B, Moore C. The link between multiple sclerosis and depression. Nat Rev Neurol. 2014;10:507–17.CrossRefPubMed
38.
go back to reference Leonavicius R, Adomaitiene V. Features of sleep disturbances in multiple sclerosis patients. Psychiatr Danub. 2014;26:249–55.PubMed Leonavicius R, Adomaitiene V. Features of sleep disturbances in multiple sclerosis patients. Psychiatr Danub. 2014;26:249–55.PubMed
39.
go back to reference Dennison L, Moss-Morris R, Chalder T. A review of psychological correlates of adjustment in patients with multiple sclerosis. Clin Psychol Rev. 2009;29:141–53.CrossRefPubMed Dennison L, Moss-Morris R, Chalder T. A review of psychological correlates of adjustment in patients with multiple sclerosis. Clin Psychol Rev. 2009;29:141–53.CrossRefPubMed
Metadata
Title
Prevalence and risk factors for depression in women with multiple sclerosis: a study from Iran
Authors
Khadijeh Mohammadi
Parvin Rahnama
Ali Montazeri
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Annals of General Psychiatry / Issue 1/2015
Electronic ISSN: 1744-859X
DOI
https://doi.org/10.1186/s12991-015-0069-8

Other articles of this Issue 1/2015

Annals of General Psychiatry 1/2015 Go to the issue